245 related articles for article (PubMed ID: 18098308)
1. Prognostic value of postsurgical stimulated thyroglobulin levels after initial radioactive iodine therapy in well-differentiated thyroid carcinoma.
Sawka AM; Orlov S; Gelberg J; Stork B; Dowar M; Shaytzag M; Tabatabaie V; Freeman JL; Walfish PG
Head Neck; 2008 Jun; 30(6):693-700. PubMed ID: 18098308
[TBL] [Abstract][Full Text] [Related]
2. Predictive value of serum thyroglobulin after surgery for thyroid carcinoma.
Hall FT; Beasley NJ; Eski SJ; Witterick IJ; Walfish PG; Freeman JL
Laryngoscope; 2003 Jan; 113(1):77-81. PubMed ID: 12514386
[TBL] [Abstract][Full Text] [Related]
3. Serum thyroglobulin concentrations predict disease-free remission and death in differentiated thyroid carcinoma.
Heemstra KA; Liu YY; Stokkel M; Kievit J; Corssmit E; Pereira AM; Romijn JA; Smit JW
Clin Endocrinol (Oxf); 2007 Jan; 66(1):58-64. PubMed ID: 17201802
[TBL] [Abstract][Full Text] [Related]
4. Thyroglobulin measurement before rhTSH-aided 131I ablation in detecting metastases from differentiated thyroid carcinoma.
Giovanella L; Ceriani L; Suriano S; Ghelfo A; Maffioli M
Clin Endocrinol (Oxf); 2008 Oct; 69(4):659-63. PubMed ID: 18363882
[TBL] [Abstract][Full Text] [Related]
5. Influence of age and primary tumor size on the risk for residual/recurrent well-differentiated thyroid carcinoma.
Orlov S; Orlov D; Shaytzag M; Dowar M; Tabatabaie V; Dwek P; Yip J; Hu C; Freeman JL; Walfish PG
Head Neck; 2009 Jun; 31(6):782-8. PubMed ID: 19260133
[TBL] [Abstract][Full Text] [Related]
6. A model for predicting outcomes in patients with differentiated thyroid cancer and model performance in comparison with other classification systems.
Yildirim E
J Am Coll Surg; 2005 Mar; 200(3):378-92. PubMed ID: 15737848
[TBL] [Abstract][Full Text] [Related]
7. Operative strategy for follicular thyroid cancer in risk groups stratified by pTNM staging.
Lin JD; Chao TC; Chen ST; Huang YY; Liou MJ; Hsueh C
Surg Oncol; 2007 Aug; 16(2):107-13. PubMed ID: 17600699
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the diagnostic value of the first thyroglobulin determination in detecting metastases after differentiated thyroid carcinoma surgery.
Makarewicz J; Adamczewski Z; Knapska-Kucharska M; Lewiński A
Exp Clin Endocrinol Diabetes; 2006 Oct; 114(9):485-9. PubMed ID: 17115345
[TBL] [Abstract][Full Text] [Related]
9. Elevated serum thyroglobulin. A marker of metastases in differentiated thyroid carcinomas.
Herle AJ; Uller RP
J Clin Invest; 1975 Aug; 56(2):272-7. PubMed ID: 1150869
[TBL] [Abstract][Full Text] [Related]
10. Total thyroidectomy and adjuvant radioiodine treatment independently decrease locoregional recurrence risk in childhood and adolescent differentiated thyroid cancer.
Handkiewicz-Junak D; Wloch J; Roskosz J; Krajewska J; Kropinska A; Pomorski L; Kukulska A; Prokurat A; Wygoda Z; Jarzab B
J Nucl Med; 2007 Jun; 48(6):879-88. PubMed ID: 17536106
[TBL] [Abstract][Full Text] [Related]
11. [After care of differentiated thyroid gland carcinoma with special reference to serum thyroglobulin level].
Kanitz W; Böttger IG; Pabst HW; Heidenreich P; Dirr W
Rofo; 1987 Sep; 147(3):282-7. PubMed ID: 2823333
[TBL] [Abstract][Full Text] [Related]
12. Thyroglobulin measurements in the follow-up of patients with differentiated thyroid carcinoma: comparison with quantitative radioactive iodine uptake measurements and total body scans.
Bolk JH; Bussemaker JK; Nieuwenhuijzen Kruseman AC; De Vijlder JJ; Goslings BM
Neth J Med; 1985; 28(9):340-6. PubMed ID: 4047268
[No Abstract] [Full Text] [Related]
13. Radioactive iodine treatment in medullary thyroid carcinoma.
Faik Erdogan M; Gursoy A; Erdogan G; Kamel N
Nucl Med Commun; 2006 Apr; 27(4):359-62. PubMed ID: 16531922
[TBL] [Abstract][Full Text] [Related]
14. [Basic policy for postsurgical follow-up of patients with differentiated thyroid carcinoma--guidelines from abroad].
Hamada N
Nihon Rinsho; 2007 Nov; 65(11):2061-7. PubMed ID: 18018571
[TBL] [Abstract][Full Text] [Related]
15. Postsurgical management of differentiated thyroid carcinoma.
Mazzaferri EL; Robyn J
Otolaryngol Clin North Am; 1996 Aug; 29(4):637-62. PubMed ID: 8844735
[TBL] [Abstract][Full Text] [Related]
16. [Thyroglobulin: usefulness and limits in monitoring patients with thyroid carcinoma].
Hammami H; Sellem A; Ben Sellem D; Aouni Z; Elabri SB; Mezigh C; Machghoul S; Ben Brahim H
Tunis Med; 2007 Feb; 85(2):128-30. PubMed ID: 17665659
[TBL] [Abstract][Full Text] [Related]
17. Recombinant human thyroid-stimulating hormone (Thyrogen) in thyroid cancer follow up: experience at a single institution.
Wong R; Topliss DJ; Bach LA; Hamblin PS; Kalff V; Long F; Stockigt JR
Intern Med J; 2009 Mar; 39(3):156-63. PubMed ID: 19383064
[TBL] [Abstract][Full Text] [Related]
18. Papillary thyroid microcarcinoma (PTMC): prognostic factors, management and outcome in 403 patients.
Pelizzo MR; Boschin IM; Toniato A; Piotto A; Bernante P; Pagetta C; Rampin L; Rubello D
Eur J Surg Oncol; 2006 Dec; 32(10):1144-8. PubMed ID: 16872798
[TBL] [Abstract][Full Text] [Related]
19. Low but measurable stimulated serum thyroglobulin levels <2 µg/L frequently predict incomplete response in differentiated thyroid cancer patients.
Aldawish M; Jha N; McEwan AJ; Severin D; Ghosh S; Morrish DW
Endocr Res; 2014; 39(4):157-63. PubMed ID: 24460082
[TBL] [Abstract][Full Text] [Related]
20. Post-ablative serum thyroglobulin is an independent predictor of recurrence in low-risk differentiated thyroid carcinoma: a 16-year follow-up study.
Pelttari H; Välimäki MJ; Löyttyniemi E; Schalin-Jäntti C
Eur J Endocrinol; 2010 Nov; 163(5):757-63. PubMed ID: 20813788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
